Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV (Q70247981)
Jump to navigation
Jump to search
scientific article published on 01 January 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV |
scientific article published on 01 January 1990 |
Statements
Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV therapeutic agents (English)
D M Rausch
K M Hwang
M Padgett
A H Voltz
A Rivas
E Engleman
I Gaston
M McGrath
B Fraser
V S Kalyanaraman